Dr Daniel Schwartz https://validator.w3.org/feed/docs/rss2.html Preventative Foot Care Project May Reduce Amputations, Hospitalization and Length of Stay in ESRD Most impactful clinical trials: slowing progression of chronic kidney disease Should patients w/ diabetes, CKD and proteinuria despite RAASi & SGLT2i be considered for add-on therapy with finerenone (triple therapy)? 10 Opportunities to increase access to physicians through IT efficiencies Tips for starting an SGLT2 inhibitor Temporary Visitor Visas for Donating a Kidney Personalized decision support and the move from NNT to iNNT 7 ways the EMPA-KIDNEY trial will impact clinical care in CKD Will SPRINT Change Our Systolic BP Target in Hypertensive Patients from 140 to 120 mm Hg? PharmaCare in BC: Bridging the Gaps in Prescription Coverage The flood of new medical information Reducing the Cost of Pharmaceutical Drugs in Canada Home